Jiangsu gdk Biotechnology Co., Ltd.
Status: Publicly traded
Direct answer
Jiangsu gdk Biotechnology Co., Ltd. is publicly traded on SHH under the ticker 688670.SS.
Jiangsu gdk Biotechnology Co., Ltd. operates as a biotechnology firm specializing in the comprehensive research, development, manufacturing, and commercialization of human vaccines, alongside providing related services. Its current portfolio includes a quadrivalent split-virus influenza vaccine and a lyophilized human rabies vaccine. The company's pipeline is strategically focused on preventing major infectious...
Can you invest in Jiangsu gdk Biotechnology Co., Ltd.?
Yes. Jiangsu gdk Biotechnology Co., Ltd. trades publicly on SHH as 688670.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Jiangsu gdk Biotechnology Co., Ltd.
Detailed equity research is provided by MarketSnap.